Menelas Pangalos commenced his scientific career with an undergraduate degree in Biochemistry from the Imperial College of Science and Technology, London and a subsequent Doctor of Philosophy in Neurochemistry from the Institute of Neurology, London. His post-doctoral training was conducted under the tutelage of Professor North.K. Robakis at the Mount Sinai Medical Center, New New York
He is best known for his work on the discovery and development of novel drugs to treat Alzheimer"s disease, and was recently listed as an “R&Doctorate Difference-Maker” by R&Doctorate Directions magazine, for his efforts in the field of Alzheimer’s drug discovery. He is the author of over 100 publications in scientific journals. Menelas Pangalos was appointed head of the Innovative Medicines (iMed) unit of on May 1, 2010.
Menelas Pangalos was the Vice President of Neuroscience Research at, a leading pharmaceutical company.
He held this role from 2003 to He was responsible for overseeing the transition of more than 20 novel drug candidates into clinical development for a number of neurological and psychiatric diseases including Alzheimer’s disease, Stroke, Schizophrenia, and Pain.
He previously served as Group Director and Head of Neurodegenerative Research at GlaxoSmithKline in Harlow, United Kingdom, and has held positions with SmithKline Beecham Beecham, Janssen Pharmaceutica and Bristol-Myers Squibb. Menelas Pangalos is an Adjunct Professor of Neuroscience at the University of Pennsylvania and a Visiting Professor at King"s College London.
He is on the editorial boards of Molecular and Cellular Neuroscience, Neuropharmacology and The Scientific World and on scientific advisory boards for the Wolfson Centre for Age-Related Diseases (King’s College London University) and Rider University.
Doctor Pangalos has edited the book “Understanding G protein-coupled receptors in the Central Nervous System”, as well as a number of journal issues focused on drug discovery in the Central Nervous System.
He has previously served on the Biotechnology and Biological Sciences Research Council Molecular and Cell Biology council and is a member of the American Society for Neuroscience, British Pharmacological Society and an Associate of the Royal College of Science.
